Articles tagged with Analgesics
Anxiety disorders are common in primary care settings, affecting nearly 20% of patients, with many untreated. Internists perform fewer procedures than in 1986, with a significant decrease in varied procedures. Annals of Internal Medicine launches a reproducible research initiative to improve data sharing.
Two large studies found a significant association between common pain-relieving medications and an increased risk of hypertension (high blood pressure) in men. Men who regularly took acetaminophen, ibuprofen, or aspirin were more likely to develop high blood pressure over four years.
A new clinical trial aims to investigate whether low-dose aspirin can improve pregnancy outcomes for women who have miscarried. The study will enroll 535 women and follow them for five years to assess the impact of aspirin on implantation, blood flow, and preeclampsia.
Researchers at Brown University have identified a critical pain pathway that explains why opioids are effective in blocking pain signals. By understanding how these channels work, drug companies can develop more effective painkillers.
A new risk-factor list for postmenopausal women could help reduce cardiovascular disease deaths by incorporating family history and C-reactive protein. The updated criteria may change the risk scores for at least 20% of studied women.
A study published in Neurology found that smoking marijuana reduced nerve pain in people with HIV-associated sensory neuropathy by 34%, compared to 17% for those who received a placebo. The study also showed significant relief from chronic pain, with an average reduction of 72%.
A Phase IV study found that Kadian's extended-release mechanism is maintained even in the presence of significant amounts of alcohol. The concomitant use of tested levels of alcohol with Kadian has no significant impact on morphine blood levels or release timing.
Researchers investigated opioid analgesic abuse and found it is more prevalent in rural areas, with teenagers increasingly affected. Spinal cord stimulation also showed significant results in managing axial low back pain associated with failed back surgery syndrome.
Research reveals a link between doctors' personal fear of death and their willingness to hasten life-sustaining treatment in severely disabled newborns. One in three specialists use painkillers to relieve suffering without intending to hasten death, while over three-quarters would do so if further treatment is deemed futile.
Chronic pain has increased by 26% among US workers over the past decade, with most employees experiencing moderate to severe pain while still attending work. Employers are encouraged to invest in workplace wellness programs addressing chronic pain, as only 22% currently include such components.
Researchers at University of Texas M. D. Anderson Cancer Center found that aspirin significantly improves survival rates among cancer patients with low platelet counts who experience heart attacks, even when taking anticoagulants. Aspirin also showed benefits for patients with normal platelet counts.
A large randomized controlled trial found that taking low-dose aspirin every other day can reduce the risk of newly diagnosed adult-onset asthma by 22 percent. The study, published in the American Journal of Respiratory and Critical Care Medicine, involved over 22,000 healthy male physicians aged 40 to 84 years.
A University of Georgia study found that moderate doses of caffeine reduce post-workout muscle pain by up to 48 percent in women. Caffeine works by blocking the body's receptors for adenosine, a chemical released in response to inflammation.
Researchers have discovered that aspirin forms crystals containing both long-known and predicted structures, upending fundamental principles. The two 'polymorphic' forms exist in one single crystal, raising questions about the definition of polymorphism and its implications for patent law.
A team of Cambridge-led researchers has identified a genetic mutation that renders carriers pain-insensitive. The study reveals the role of the SCN9A gene in pain sensation and may lead to new, safer pain medications.
Research suggests that common painkillers like NSAIDs can reduce vaccine effectiveness by reducing antibody production. The study's findings have implications for people who take these medications regularly, particularly those with compromised immune systems.
A study published in Neurology found that pregabalin significantly reduced severe pain and anxiety problems in patients with moderate to severe nerve pain after spinal cord injury. The medication was effective in relieving pain, improving sleep, and overall well-being.
A study conducted by Dr. Benedikt Fischer and his team reveals that prescription opioids are the major form of illicit opioid use in seven Canadian cities, surpassing heroin use. The findings suggest a significant decline in heroin use among participants between 2001 and 2005.
A study analyzed 227 adult patients with neck pain who participated in a larger prospective, randomized, open-label study. After four weeks, patients reported a 30.7% reduction in pain intensity, suggesting that Kadian offers broad utility for even the most disabling types of chronic pain.
A new analysis by Duke University Medical Center cardiologists found that taking low-dose aspirin daily reduces the risk of heart attack, stroke, and death among patients with stable cardiovascular disease. The study also showed an increased risk of bleeding, but the protective benefits of aspirin outweigh this side effect.
A study found that eating small amounts of dark chocolate daily can decrease the tendency of platelets to clot in narrow blood vessels, reducing heart attack risk. Researchers analyzed blood samples from 139 'chocolate offenders' who were excluded from a larger aspirin study and found them to be less reactive than those who abstained.
Researchers found a new approach to treating chronic and debilitating neuropathic pain by blocking the alpha9alpha10 nicotinic acetylcholine receptor. The study suggests a previously unrecognized molecular mechanism for treating this condition, which affects hundreds of millions of people worldwide.
Researchers found that synthetic antioxidants significantly reduced pain-like behavior in mice with inflamed hind paws, with 70-90% reduction during acute phase and 78-98% reduction during tonic phase. This suggests that antioxidants may fight chronic pain by helping the body break down free radicals.
Research shows that people who feel in control of their lives are less effective at coping with pain when it's beyond their control. Teaching psychological coping strategies helps reduce pain effects. The study suggests acceptance-based therapy may be a more effective approach to managing persistent pain.
A recent study by Dartmouth researchers found that individuals with a specific genetic variation in their ODC gene are more likely to benefit from aspirin use in preventing colon cancer. These individuals were 23% less likely to develop new adenomas and 49% less likely to develop more advanced lesions.
A specific gene variant, GCH1, affects both acute and chronic pain sensitivity in humans. The protective version of the gene reduces the risk of developing chronic post-surgical pain.
A new study from the University of Michigan finds that the brain chemical dopamine is involved in both pleasure and pain responses, with variations between individuals affecting vulnerability to drug addiction. The research may help explain why some people are more prone to developing addictions during times of stress or chronic pain.
A new study found that only 33.3% of patients with locally advanced colorectal cancer received the recommended extensive surgery, which reduces local recurrence and improves survival rates. Aspirin takers with a specific genetic variant showed lower risk of developing colorectal adenomas.
Researchers have discovered aspirin's ability to prevent blood vessel formation, a crucial step in tumor growth. By targeting this process, scientists can develop entirely new types of cancer-fighting drugs.
A study found that physicians prescribed new medications without adequately explaining key information, including side effects and dosing instructions. Patients who receive complete instructions are more likely to adhere to treatment plans.
Healthcare providers must weigh benefits and risks of NSAID use, which are associated with gastrointestinal complications. The AGA Institute recommends lower-risk agents and gastroprotection methods for patients at high risk of GI complications.
Low-dose aspirin treatment may cause an extra case of gastrointestinal complications, such as ulcer bleeding or perforation, in susceptible groups. The authors conclude that for some patients taking aspirin to reduce their risk of heart attack, the risk of gastrointestinal complications might outweigh the cardioprotective effects.
Researchers at Cardiff University have found a link between low nitric oxide levels and increased risk of heart attack and stroke in patients taking NSAIDs. Lower nitric oxide levels may make individuals more susceptible to cardiovascular side effects from these medications.
A recent study by Robert J. Gatchel confirmed that patients scoring high on the Pain Medication Questionnaire (PMQ) test demonstrate higher levels of substance abuse, psychopathology, and physical/life functioning problems. The study found that patients in the high-PMQ group are 3.2 times more likely to request early medication refills.
A study by Mayo Clinic researchers found that men who took nonsteroidal anti-inflammatory drugs (NSAIDs) had a 50 percent lower risk of developing an enlarged prostate and a 35 percent lower risk of moderate to severe urinary symptoms compared to non-users.
A newly discovered enzyme inhibitor identified by researchers looking for pest controls may provide pain relief for arthritis and inflammatory diseases sufferers. The finding, hailed as the most important discovery in inflammation in over a decade, reduces side effects associated with painkillers like Vioxx.
A new synthetic treatment has been discovered that uses cooling chemicals to kill pain, targeting the TRPM8 receptor in human skin. This approach may offer a more effective and safer alternative to conventional painkillers for chronic pain patients.
Researchers have identified a protein called TRPM8 that mediates sensations of coolness and is expressed in nerve cells in the skin, responding to both cool temperatures and cooling chemicals like mint oil. This discovery has great potential for relieving chronic pain patients with approaches using cooling compounds
A small study found that TV effectively reduces kids' pain scores, with passive distraction being more effective than active distraction. Watching TV increases children's pain tolerance, making it a useful tool for minor procedures.
A study found that exposure to similar logos reduces brand-exclusive recall by one-third, on average. Consumers' relative knowledge of the two product categories also impacts retrieval.
A study published by the University of Kentucky found that smokers with chronic pain tend to smoke at higher rates than those without pain. However, over half of these smokers are considering quitting. The research suggests that addressing smoking cessation as part of pain management could lead to improved health outcomes.
A study found that UK recommendations on paracetamol availability are not being followed, with many pharmacies and outlets selling more than 16 tablets at a time. The researchers discovered that almost half of patients who visited the emergency department for paracetamol poisoning had deliberately bought the medication for an overdose.
A recent study found that prescription painkillers, such as oxycodone and hydrocodone, are involved in more drug overdose deaths than cocaine or heroin in the US. Overdose deaths from these drugs have increased significantly over the past 15 years, with sales of opioid painkillers rising parallel to deaths.
Researchers found that chronic ibuprofen therapy given after brain injury worsened cognitive abilities in animal models. The study suggests potential implications for traumatic brain injury patients who often receive ibuprofen for chronic pain.
Researchers at Columbia University Medical Center have discovered a protein switch that activates chronic pain. The switch is an enzyme called protein kinase G (PKG), which sets off processes generating pain messages when activated. Turning PKG off relieves pain, making it a potential target for therapy.
Researchers at OHSU are testing a new device called the U-plate to aid in repairing broken ribs. The study aims to identify individuals who benefit most from surgical repair versus nonsurgical therapy.
A new treatment plan involving behavior modification and pharmaceutical treatment has shown marked improvement in nearly half of patients with medically unexplained symptoms. The treatment also emphasizes improved communication between patient and doctor, highlighting the importance of the doctor-patient relationship.
Researchers found that combining antioxidants with a chest pain drug improves heart function after a heart attack by reducing free radical damage. The antioxidant derivatives TMZ-NH and TMZ-NH showed significant protection against tissue damage during reperfusion, leading to improved blood flow and reduced infarct size.
A study by the University of Alberta found that older farmers who stop taking prescribed pain medications are at higher risk of injury. The research identified several reasons for this, including distraction caused by pain, withdrawal symptoms, and incontinence-related discomfort.
Researchers discovered that heat, specifically above 40 degrees Celsius, blocks pain receptors by inhibiting chemical messengers. This finding has implications for developing pain relief drugs targeting P2X3 receptors.
A study found that acupuncture improved knee pain in patients with osteoarthritis, even when compared to sham acupuncture. Another study revealed that Mediterranean diets improved blood pressure, cholesterol levels, and blood sugar levels in older adults at risk for heart disease.
Researchers found that targeting women's depression can help reduce disability associated with chronic pain. Women are more likely to experience higher levels of depression and greater pain intensity than men, and may respond differently to treatments.
A Queen's University study discovered a new heterodimer formed by COX-1 and COX-2 enzymes in genetically modified mice. This finding may impact the development of alternative anti-inflammatory drugs, potentially reducing cardiovascular risks associated with existing pain medications.
A phase 3 clinical study found that nearly half of patients with advanced illness experienced laxation within four hours of receiving methylnaltrexone, and over 70% responded by the end of the first week. The treatment also showed no diminishment of analgesia due to medication.
Researchers found a link between non-steroidal anti-inflammatory drugs (NSAIDs) and an increased risk of first-time hospital admissions for heart failure in the elderly. People taking indomethacin were three times more likely to be admitted due to osteoarthritis as their reason for taking NSAIDs.
A new marijuana-derived drug, IP 751, has shown significant promise in suppressing bladder overactivity and alleviating painful symptoms in animal models of interstitial cystitis. Researchers at the University of Pittsburgh School of Medicine developed a liposome-based delivery system to overcome the hydrophobic properties of the drug.
Recent studies demonstrate improved virus suppression with novel therapy combinations for hepatitis treatment, including valopicitabine plus peg-interferon. Researchers found a higher dose of the drug showed promising results, but also led to side effects that forced dosage reduction.
A study published in The Lancet found that patients taking aspirin and dipyridamole had fewer circulatory events compared to those on aspirin alone. This combination therapy reduced the relative risk of vascular death, stroke, or heart attack by 18%.
A recent study found that acetaminophen is safe to use after a heart attack, but it does not offer any protection for the heart. The researchers tested the effects of acetaminophen on animals with induced heart attacks and found no significant impact on blood flow, heart muscle damage, or ventricular function.
A quarter of patients who suffered a heart attack while taking Vioxx did so within the first two weeks of use, new research shows. The study found that cardiovascular risk returns to normal within one month of stopping the drug.